Ipilimumab versus placebo after complete resection of stage III melanoma: Long-term follow-up results the EORTC 18071 double-blind phase 3 randomized trial.
暂无分享，去创建一个
P. Ascierto | R. Dummer | J. Wolchok | A. Eggermont | A. Testori | M. Smylie | H. Schmidt | J. Grob | V. Chiarion-Sileni | C. Robert | M. Maio | C. Lebbé | O. Hamid | J. Weber | S. Suciu | V. Ferraresi | J. Richards | F. Hosein | V. de Pril | M. Kicinski